---
title: "Key facts: Infosys to buy Optimum Healthcare IT $465M; Analyst upbeat"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280730669.md"
description: "Infosys is set to acquire Optimum Healthcare IT for up to $465 million, with Optimum's FY25 revenue reported at $275.9 million. The deal is expected to close in Q1 FY27 and could contribute approximately 1.2% to Infosys's FY27 revenue after nine months. Analyst Siddharth Khemka from Motilal Oswal Financial Services expressed optimism about Infosys's outlook following recent deals."
datetime: "2026-03-27T05:04:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280730669.md)
  - [en](https://longbridge.com/en/news/280730669.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280730669.md)
generator: "portal-rs"
---

# Key facts: Infosys to buy Optimum Healthcare IT $465M; Analyst upbeat

-   Infosys to buy Optimum Healthcare IT for up to $465M. Optimum had FY25 revenue $275.9M. Deal closes Q1 FY27 and could add ~1.2% to Infosys FY27 revenue after 9 months.1
-   Analyst Siddharth Khemka of Motilal Oswal Financial Services stated that recent Infosys (INFY) deals have strengthened the company’s outlook, according to his assessment.2

### Related Stocks

- [INFY.US](https://longbridge.com/en/quote/INFY.US.md)
- [OHCS.US](https://longbridge.com/en/quote/OHCS.US.md)

## Related News & Research

- [FOCUS-AI reshapes India's IT services sector contracts as clients demand more for less](https://longbridge.com/en/news/296543708.md)
- [Infosys Ltd. ADR Underperforms Monday When Compared To Competitors](https://longbridge.com/en/news/296830771.md)
- [Zoom Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call](https://longbridge.com/en/news/296791470.md)
- [REG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC](https://longbridge.com/en/news/296911439.md)
- [Jersey Mike's (NYSE:JMKE) Receives Average Recommendation of "Moderate Buy" from Analysts](https://longbridge.com/en/news/296790169.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**